Molecular Physiological Chemistry Laboratory, Inc. Report issue

For profit Phase 4
Founded: Tokyo Japan (2002)
Status: Left NME R&D (2014)

Organization Overview

First Clinical Trial
2014
NCT02214563
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

olive (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Bone Diseases (Phase 4)

Bone Diseases, Metabolic (Phase 4)

Kidney Failure, Chronic (Phase 4)

Metabolic Diseases (Phase 4)

Renal Insufficiency (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2